Contact the Editorial Desk

Editorial correspondence

The casebook is glad to hear about the research record: a citation quoted inaccurately, a newly published study on BPC-157, GHK-Cu, TB-500, or GHK, or a regulatory update that shifts an approval or anti-doping status. Corrections like these are the most useful notes this desk receives, and each is read closely.

The handiest submissions name the page in question, quote the exact passage being corrected or challenged, and attach the supporting reference — a DOI or PubMed identifier where possible — so a proposed change can be checked against its source before it is filed.

Editorial mailbox: editors@regenlifepeptides.com

Outside the casebook

So no message goes unanswered for the wrong reason: RegenLife Peptides keeps a literature casebook — it is neither a clinical service nor a product seller. It cannot advise on or recommend human use of any peptide here, suggest a dose or schedule for anyone, judge whether a cited finding applies to a particular person, or sell, source, or help locate any compound from any supplier. Readers seeking medical guidance should consult a licensed clinician in their jurisdiction. Replies to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.